EVERYONE'S PROSTATE CANCER STORY IS DIFFERENT—BUT TREATMENT GOALS REMAIN THE SAME
There are thousands of men, just like you, who are fighting prostate cancer that has spread to the bones. One of the reasons it may have spread is because your cancer is no longer responding to therapies aimed at lowering testosterone. The medical term for this condition is metastatic castration-resistant prostate cancer (mCRPC).
When prostate cancer spreads to your bones, a treatment change may be necessary.
It is important to know that even if the cancer has spread to your bones and you may no longer have a prostate, it is still considered prostate cancer, not bone cancer.
Your doctor may also refer to advanced prostate cancer as “metastatic” or “late-stage” disease. It may also be referred to as “mCRPC.”
How you and your doctor can monitor your disease
If your doctor suspects prostate cancer has spread to your bones, tests such as a bone scan, checking ALP levels, or a PSA test should be considered. ALP is a substance that may be released into the bloodstream when bones break down. High levels of ALP give your doctor a better idea if your disease has spread to bone.
PSA tests screen for prostate cancer but are also an important tool for men with the disease to determine how their cancer is reacting to treatment. Changes in your PSA levels may be a sign that your disease is advancing. In advanced prostate cancer, PSA tests alone should not be used to determine long-term outcomes, like living longer.
BE OPEN AND HONEST WITH YOUR DOCTORS. THIS WILL HELP THEM FIGURE OUT IF A TREATMENT CHANGE OR AN ADDITIONAL THERAPY IS THE RIGHT APPROACH FOR YOU.